Amylin Pharmaceuticals Scrip Surges On Report Of New Sale Discussions
Tue, 04/24/2012 - 09:18 | 
Shares of diabetes drug manufacturer Amylin Pharmaceuticals Inc. soared on April 23 accompanying a report the firm is reaching out to prospective buyers on a possible sale.
Sun Pharmaceutical Industries Ltd. has announced that USFDA has given nod for its Abbreviated New Drug Application for generic edition of Zyprexa, Olanzapine tabs USP, 2.5mg, 5mg, 7.5mg,10mg, 15mg and 20mg
Pfizer Pfizer is determined on throwing away noncore biz groups. AstraZeneca is intent on appending any small firm, which might bring returns.
Tags: Dainippon Sumitomo To Get Hold Of US Cancer Drug Start-Up
Dainippon Sumitomo Pharma Co. declared its plans to buy U.S. biotechnology business enterprise Boston Biomedical Inc. for $200 million, with milestone payments potentially bringing the transaction to around 2.63 billion dollars.
Sun Pharmaceutical Industries stated that it has bagged nod from the US health watchdog for its generic Zyprexa Zydis pills, utiized in handling psychological disorder, in the US market.
AstaraZeneca Pharma India stated that it is undertaking voluntary recall of sterile products fabricated at its Bangalore plant.
Hyderabad based pharmaceutical maker Cheminnova has inked a JV deal with Brisbane-based neutraceuticals company Rapid Nutrition Ltd.
Buy AstraZeneca With Target Of Rs 2250-2500; Salix Pharma Registers Profit In Q4
Aashish Tater, Head of Research, Fort Share Broking stated that the stock of AstraZeneca Pharma can be purchased to attain a target of Rs 2250-2500.
Salix Pharmaceuticals Ltd. has recorded fourth quarter net income of $33.6 million ($0.56 per share) as against $24.5 million or $0.40 per share during the same period of last year.
Raging Capital Management, LLC ("Raging Capital"), one of the largest unaffiliated shareholders of Taro Pharma declared that it forwarded a letter to the company’s board asking for that it instantly disallow the October 18, 2011 offer of Sun Pharmaceutical Industries Ltd. to get hold of all of the resting outstanding shares of Taro.
Dr Reddy’s Registers 88% Jump In Quarterly Profit
Dr Reddy’s Laboratories , the country's No. 2 drug manufacturer by sales, registered a forecast-hitting 88% increase in quarterly net profit as sales in its main U.S. market increased over two-folds.
Nirmal Bang has suggested ‘hold’ rating on Glenmark Pharma to attain a price target of Rs 364.
British drug manufacturer AstraZeneca declared that it has decided to slash costs by shutting its Quebec research and development plant, annihilating 132 jobs.
Poland's retail pharma market posted a drop of 24% year on year during the last month to PLN 1.4 billion in gross retail prices.
